approval
saveHYMPAVZI (MARSTACIMAB-HNCQ) — FDA approval
community read0 votes
Sponsor: PFIZER INC. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalABRILADA: ABRILADA (ADALIMUMAB-AFZB) — FDA approvalDec 17, 2025
- approvalmedroxyprogesterone acetate: DEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 12, 2025
- approvalmedroxyprogesterone acetate: DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalDec 12, 2025
- approvaltaliglucerase alfa: ELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 22, 2025
- approvalalprostadil: PROSTIN VR PEDIATRIC (ALPROSTADIL) — FDA approvalDec 22, 2025
- approvalnafarelin acetate: SYNAREL (NAFARELIN ACETATE) — FDA approvalNov 24, 2025
comments(0)
5-min edit window · permanent after that